neobookRx
DrugsLevel 4 LocalisationS4EYOEML

Fusidic Acid

Protein synthesis inhibitorAntibacterial

Indications

Registered South African indications:

  • Staphylococcal conjunctivitis caused by susceptible organisms 

Cautions

Contraindications

  • Hypersensitivity to the active ingredient or any of its excipients

Cautions

  • Renal impairment
  • Hepatic impairment
  • Prolonged use
    - Extended use
    - Recurrent use
  • Concomitant use of contact lenses (See additional prescribing points)

Adult dosage

Forms avail. in SA and covered in this monograph: opd 

Dosages below include:

  • International manufacturer recommendations
  • South African manufacturer recommendations

Eye infections caused by: Staphylococcus aureus, Streptococcus, Neisseria, Haemophilus, Moraxella and Corynebacteria

Specific doses based on individual indications

Please note that the dosages below should be used in combination with regional guidelines, taking into account local antibiotic sensitivities

International manufacturer recommendations

Treatment of bacterial conjunctivitis where the organism is known to be sensitive to the antibiotic

  • Ophthalmic (opd): 1 drop, into the affected eye(s), 12hrly

Treatment should be continued for at least 48hrs after the eye returns to normal


South African manufacturer recommendations

Treatment staphylococcal conjunctivitis caused by susceptible organisms

  • Ophthalmic (opd): 1 drop, into the affected eye(s), 12hrly

Treatment should be continued for two days after the eye returns to normal

Paediatric dosage

Paed. forms avail. in SA and covered in this monograph: opd

Paed. dosages below include:

  • International manufacturer recommendations
  • South African manufacturer recommendations

Eye infections caused by: Staphylococcus aureus, Streptococcus, Neisseria, Haemophilus, Moraxella and Corynebacteria

Specific doses based on individual indications

Please note that the dosages below should be used in combination with regional guidelines, taking into account local antibiotic sensitivities

International manufacturer recommendations

Treatment of bacterial conjunctivitis where the organism is known to be sensitive to the antibiotic

  • See adult dosage

South African manufacturer recommendations

Treatment staphylococcal conjunctivitis caused by susceptible organisms

  • See adult dosage

Special populations

Pregnancy

  • Safe
  • No effects during pregnancy are anticipated since systemic exposure to fusidic acid eye drops is negligible. Fusidic acid eye drops can be used during pregnancy

Breastfeeding

  • Compatible 
  • No effects on the breastfed newborn/ infant are anticipated since the systemic exposure of the breastfeeding woman to fusidic acid is negligible. Fusidic acid eye drops can be used during breastfeeding

Fertility

  • There are no clinical studies with fusidic acid eye drops regarding fertility
  • No effects on women of childbearing potential are anticipated since systemic exposure to fusidic acid eye drops is negligible

Renal Impairment

Hepatic Impairment

Elderly

Porphyria Information

Drugs in Sport

  • Permitted - No warnings

Adverse reactions

Skin and Subcutaneous Tissue Disorders

  • Eyelid oedema 
  • Rash 
  • Urticaria 

Immune, Blood and Lymphatic System Disorders

  • Hypersensitivity 
  • Angioedema 

Sensory Disorders

  • Blurred vision (transient) 
  • Increased lacrimation
  • Application site pain 
    - Eye burning 
    - Eye stinging 
  • Application site pruritus 
  • Application site discomfort/ irritation 
  • Aggravated conjunctivitis 

Interactions

No information available


Systemic interactions are unlikely since systemic exposure after application of fusidic acid eye drops is negligible

Monitoring

None routine

Prescribing points

Concomitant use of contact lenses

  • Contact lenses should not be worn/ used when fusidic acid eye drops are used. The microcrystalline fusidic acid may cause scratches in the contact lens or cornea. Contact lenses are kept out until all symptoms of the infection have gone
  • Fusidic acid eye drops contain benzalkonium chloride, which may cause eye irritation and discolour soft contact lenses

Directions for administration (for patients)

  • As with any eye preparation, wash your hands before you administer fusidic acid viscous eye drops
  • Remove the cap from the tube
  • To administer fusidic acid viscous eye drops, stand or sit comfortably and tilt your head backwards
  • Hold the tube above your eye
  • Gently pull down your lower eyelid and squeeze one drop from the tube into your lower eyelid
  • You may find a mirror useful when administering the drops
  • Be careful not to touch the tip of the tube to your eye or other surfaces, so as to avoid contamination of tube contents
  • Fusidic acid viscous eye drops come out of the tube as a single viscous drop, which quickly turns to liquid in your eye
  • If the drops are for children, you may put the drops in their eyes when they are lying down or asleep

Mechanism of action

Fusidic acid is a potent antibacterial agent. Fusidic acid eye drops are active against a wide range of gram-positive organisms, particularly Staphylococcus aureus.

Spectrum of activity: Staphylococcus aureus, Streptococcus, Neisseria, Haemophilus, Moraxella and Corynebacteria

Dosage forms

  • Eye ointment

Formulation

Eye drops (per g) 10mg

  • Fucithalmic (Pharmaco) originator

Also available in the following forms: Cream, ointment, suspension, tablet and injection.

References

1. SAMF_12th Edition_Page 571 2. SmPC: Fusidic Acid 1% Viscous Eye Drops, ADVANZ Pharma:Last updated on eMC: 12 Apr 2018; Downloaded online 28 Jan 2019 [https://www.medicines.org.uk/emc/medicine/28430] 3. PI: Intercom: Fucithalmic opthalmic drops, Amdipharm:Date of registration: Aug 1989 [https://drive.google.com/drive/folders/0B0xnChtF7vdueE56bV8wNkV0S1U] 4. U2D: Fusidic acid (ophthalmic): Drug information; Uptodate;Downloaded online 28 Jan 2019 [https://www.uptodate.com/contents/fusidic-acid-ophthalmic-drug-information?source=search_result&search=fusidic%20acid&selectedTitle=1~31] 5. PI: Fucithalmic opthalmic drops, Amdipharm:Date of registration: Aug 1989 [https://drive.google.com/drive/folders/0B0xnChtF7vdueE56bV8wNkV0S1U] 6. NAPOS: The Drug Database for Acute Porphyria: Fusidic acid; Accessed online 28 Jan 2019 [http://www.drugs-porphyria.org/languages/UnitedKingdom/s3.php?atc_code=S01AA13&l=gbr] 7. South African Institute for Drug-Free Sport: Fucithalmic drops; Accessed online 28 Jan 2019 [http://www.drugfreesport.org.za/online-medication-check/] 8. Clinical Pharmacologist - Dr. M Irhuma; 29 Jan 2019 [https://trello.com/c/6FmhtwXR/210-fusidic-acid-opd-pregnancy-and-breastfeeding] 9. SmPC: Fusidic Acid 1% Viscous Eye Drops, ADVANZ Pharma: Last updated on eMC: 26 Apr 2021: Downloaded online 24 May 2021 [https://drive.google.com/drive/folders/1kJKD2gPZi2KzpR-ZJ61FGD7iDRFB8ACy] 10. SmPC: Fucidin 20 mg/g Cream, Leo Laboratories Limited: Last updated on eMC: 24 Dec 2019; Downloaded online 23 May 2021[https://drive.google.com/drive/folders/0B0xnChtF7vdueE56bV8wNkV0S1U] **No PI found on SAHPRA repository**24 May 2021

Brands & products

1 product · cached snapshot
Trade names (1)
  • Fucithalmic

EYOEye ointment· 1 product

from R120.68
ProductStrengthPackApplicantMin price
Fucithalmic10 mg/g5Pharmaco Distribution (Pty) LtdR120.68

Medical aid coverage

data not yet integrated
Discovery Health
not yet integrated
  • Comprehensive Series—
  • Executive Plan—
  • KeyCare Series—
  • Priority Series—
  • Saver Series—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

Bonitas Medical Fund
not yet integrated
  • BonClassic—
  • BonComprehensive—
  • BonEssential—
  • BonFit Select—
  • BonSave—
  • BonStart—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

GEMS — Government Employees Medical Scheme
not yet integrated
  • Beryl—
  • Emerald—
  • Onyx—
  • Ruby—
  • Sapphire—
  • Tanzanite One—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

POLMED — Police Medical Aid Scheme
not yet integrated
  • Aquarium Option—
  • Efficiency Option—
  • Marine Option—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

Interacts with 10 known drugs

Check against other drugs →

Cited in 2 documents

NeoHealth® ID 16083 · updated 7/26/2023